Safety Study of GSK Biologicals' Rotarix (Rotavirus Vaccine, Live, Oral) Administered to a Birth Cohort in United States Health Insurance Plans.
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2017
At a glance
- Drugs RIX 4414 (Primary) ; Poliovirus vaccine inactivated
- Indications Poliomyelitis; Rotavirus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 07 Feb 2017 Status changed from active, no longer recruiting to completed.
- 26 Jun 2015 Planned End Date changed from 1 Jun 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.
- 26 Jun 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.